Oxygen deficit and H2S in hemorrhagic shock in rats by Andry Van de Louw & Philippe Haouzi
RESEARCH Open Access
Oxygen deficit and H2S in hemorrhagic shock
in rats
Andry Van de Louw and Philippe Haouzi*
Abstract
Introduction: Hemorrhagic shock induced O2 deficit triggers inflammation and multiple organ failure (MOF).
Endogenous H2S has been proposed to be involved in MOF since plasma H2S concentration appears to increase in
various types of shocks and to predict mortality. We tested the hypothesis that H2S increases during hemorrhagic
shock associated with O2 deficit, and that enhancing H2S oxidation by hydroxocobalamin could reduce
inflammation, O2 deficit or mortality.
Methods: We used a urethane anesthetized rat model, where 25 ml/kg of blood was withdrawn over 30 minutes.
O2 deficit, lactic acid, tumor necrosis factor (TNF)-alpha and H2S plasma concentrations (Siegel method) were
measured before and after the bleeding protocol in control animals and animals that received 140 mg/kg of
hydroxocobalamin. The ability to oxidize exogenous H2S of the plasma and supernatants of the kidney and heart
homogenates was determined in vitro.
Results: We found that withdrawing 25 ml/kg of blood led to an average oxygen deficit of 122 ± 23 ml/kg. This
O2 deficit was correlated with an increase in the blood lactic acid concentration and mortality. However, the low
level of absorbance of the plasma at 670 nm (A670), after adding N, N-Dimethyl-p-phenylenediamine, that is, the
method used for H2S determination in previous studies, did not reflect the presence of H2S, but was a marker of
plasma turbidity. There was no difference in plasmatic A670 before and after the bleeding protocol, despite the
large oxygen deficit. The plasma sampled at the end of bleeding maintained a very large ability to oxidize
exogenous H2S (high μM), as did the homogenates of hearts and kidneys harvested just after death.
Hydroxocobalamin concentrations increased in the blood in the μM range in the vitamin B12 group, and
enhanced the ability of plasma and kidneys to oxidize H2S. Yet, the survival rate, O2 deficit, H2S plasma
concentration, blood lactic acid and TNF-alpha levels were not different from the control group.
Conclusions: In the presence of a large O2 deficit, H2S did not increase in the blood in a rat model of untreated
hemorrhagic shock. Hydroxocobalamin, while effective against H2S in vitro, did not affect the hemodynamic profile
or outcome in our model.
Introduction
The severity of a shock secondary to an acute hemorrhage
is not simply dictated by the volume of blood loss [1,2].
Rather, the prognosis of a hemorrhagic shock is linked to
a cascade of events, occurring during both the phase of
bleeding and resuscitation, related to the magnitude of the
oxygen deficit [3-6] and the resulting ischemic and post-
ischemic inflammatory response [7,8]. Indeed, hemorrha-
gic shock precipitates inflammatory cascades that
comprise the activation of stress transcriptional factors
and up-regulation of cytokines synthesis [9,10] leading to
multiple organ failure [10]. Among the putative actors
involved in the fatal course of an acute hemorrhage
induced tissue ischemia/hypoxia, a novel candidate has
been recently put forward: endogenous hydrogen sulfide
[11,12]. Endogenous H2S, a newly described gaso-trans-
mitter [13], has been shown to increase during and follow-
ing an acute hemorrhage [11] and to act as a powerful
pro-inflammatory agent in various animal models [14-17].
In humans, endogenous H2S has been proposed 1) to
increase in the blood up to 100 μM concentrations during
various forms of shock [18] and 2) to be a predictor of
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survival [18]. Although the mechanism of H2S production
remains to be clarified in shock, this by-product of
cysteine metabolism appears to increase under hypoxic
conditions [19,20] and has been more recently suggested
to contribute to the response to hypoxia [19,21-23],
although this notion has been challenged [24-26]. One of
the working hypotheses is that in hypoxic conditions, the
level of H2S oxidation in the cells and mitochondria is
diminished [23]; in turn, the accumulation of this gas was
proposed to transduce the physiological response to
hypoxia in the vessels or the arterial chemoreceptors [23],
but also an unwanted inflammatory response in other
tissues [27].
Many questions on the role of H2S in hemorrhage,
however, remain to be clarified: there are, for instance,
many reasons to believe that H2S cannot accumulate in
the blood [28,29]. Indeed, the view that H2S increases in
conditions associated with a hemorrhagic shock must be
reconciled with the ability of the blood, the cytoplasm
of most cells and the mitochondria to oxidize very large
amounts of sulfide [29,30], which should prevent H2S
from rising even at low PO2 [24]. One should also
reconcile the view that H2S concentrations could rise in
the body and has deleterious effects with 1) the levels of
sulfide found during H2S intoxication (see [31] for dis-
cussion), which are much lower than those reported in
shock [18], and 2) the observations that exogenous H2S
appears to be beneficial [32-34]. The clinical significance
of such a beneficial effect remains the subject of debate
[35].
We have recently investigated the effects of cobalt in
the form of hydroxocobalamin on H2S oxidation [30].
Injection of a large dose of vitamin B12 (at a level simi-
lar to that used in cyanide intoxication) dramatically
increases the oxidative capacity of the blood and tissues
(the kidney and to a lesser extent, the heart) for H2S in
the rat, possibly via the presence of oxidized cobalt [30].
Acting on H2S oxidation in conditions associated with a
reduction in oxidative mitochondrial metabolism may,
however, represent a way to: 1) test the possible role of
endogenous H2S in clinically relevant conditions, such
as hemorrhage induced tissue ischemia, and 2) evaluate
potential novel therapeutic approaches in hemorrhagic
shock.
The aim of this study was to determine in a model of
untreated hemorrhagic shock in spontaneously breathing
urethane anesthetized rats, wherein a large O2 deficit can
be produced; 1) the putative changes in H2S concentra-
tion in blood induced by this model of shock and 2) the
potential benefit of large doses of vitamin B12 injected
before the onset of the hemorrhage. The effects of the
presence of μM levels of vitamin B12 in the blood and
tissues on the survival at one hour, on the level of lactic
acidosis, TNF-alpha and on O2 deficit accumulated
during and following the period of hemorrhage were
investigated, in keeping with the ability of blood and tis-
sues (kidney and heart) to oxidize H2S. The possibility of
bias accounting for the discrepancy between the low-
expected and high-reported changes in H2S in humans
was also investigated using the same methodological
approaches as in published studies [11,16,18]. The
hypothesis tested in this study is that H2S increases along
with inflammatory markers when O2 deficit develops
during a hemorrhagic shock, and that increasing the oxi-
dative property of the blood and tissues for H2S by the




After approval from the Pennsylvania State University
College of Medicine Institutional Animal Care and Use
Committee, a total of 17 adult Sprague-Dawley rats (470 ±
43 g) were prepared as follows: anesthesia was induced
with 3.5% isoflurane in O2 followed by intra-peritoneal
injection of 1.2 g/kg of urethane (Sigma-Aldrich, St Louis,
MO, USA). A polyethylene PE-50 catheter was inserted
into the left femoral artery for blood withdrawal and arter-
ial blood pressure (ABP) monitoring (Cybersense, Nicho-
lasville, KY, USA). The animals were tracheostomized and
the tracheostomy was connected to a small dead space
two-way valve [24]. The inspiratory port of the valve was
connected to a calibrated pneumotachograph (Hans
Rudolph Inc., KS, USA, 8420 series, Kansas city, MO,
USA) to measure inspiratory flow. The rats were breathing
spontaneously in room air during the entire protocol.
Their body temperature was monitored using a rectal
probe and was kept at 35 to 36°C throughout the surgery
and the hypovolemia using a pad heated at a constant
temperature.
Protocol
Immediately after surgery, the rats received an intraperi-
toneal (I.P.) injection of either 140 mg/kg hydroxocobala-
min (vitamin B12a, Sigma-Aldrich, 60 mg/ml) in saline
(vitamin B12 group, n = 9), or an equivalent volume of
saline (2.3 ml/kg, control group, n = 8). Each rat receiv-
ing saline or vitamin B12 was randomly chosen among a
homogenous group of rats of similar age and weight.
Thirty minutes after I.P. injection, hemorrhage was
initiated by withdrawing 2.5 ml/100 g of blood over
about 30 minutes as follows: 0.5 ml/100 g were with-
drawn over 3 minutes, every 6 minutes (5 sessions).
Blood gas analysis and lactate measurements were per-
formed just before and at the end of the hemorrhage per-
iod (i-STAT-1 blood gas analyser, Abaxis, Union City,
CA, USA). The first and last samples of blood withdrawn
were also used for H2S and vitamin B12 determinations
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(see below). Plasma was collected by centrifuging the
blood 15 minutes at 13,000 rpm, and then frozen for the
determination of TNF-alpha levels and of the ability of
the plasma to oxidize H2S (see below). No fluid was
administered except for flushing the arterial catheter
with a fixed volume of 0.2 ml of heparinized saline after
each period of bleeding. After the hemorrhage period,
data were continuously recorded until the death of the
animal.
Measurements and data analysis
The inspiratory flow ( V˙ ) and arterial pressure signals
were digitized by analog-to-digital converter at 200 Hz
(LabView 8.5, National Instruments, Austin, TX, USA).
Analysis of data was performed offline using Powerchart
software (Chart 5, AD Instruments, Colorado Springs,
CO, USA). Breathing frequency (f) and tidal volume
(VT) were respectively determined using peak detection
and integration of the inspiratory flow signal. Minute
ventilation (V˙I ) was computed in body temperature and
pressure saturated (BTPS) conditions as f × VT.
In 10 animals (4 controls and 6 hydroxocobalamin-
treated rats), a 7 ml mixing chamber was connected to
the expiratory port of the valve, where mixed expiratory
gas composition was continuously sampled and analyzed
(GEMINI, CWE Inc., Ardmore, PA, USA). O2 uptake
(V˙O2 ) was computed in standard temperature and pres-
sure, dry (STPD) condition using V˙I , the inspiratory
and expiratory fractions of O2 and CO2. V˙E was com-
puted as V˙IBTPS (1-FIO2-FICO2/1-FEO2-FECO2) and
V˙O2 as (V˙ISTPD FEO2)− (V˙ESTPDFEO2) . The same
approach was used to calculate V˙CO2 as V˙ESTPDFEO2 .
Oxygen deficit (ml/kg) was computed as the integral of
difference between pre-hemorrhage V˙O2 (averaged over
five minutes) and V˙O2 (t) throughout the hemorrhagic
period, then until death occurred. All signals were also
displayed on line for monitoring.
Hydroxocobalamin concentrations in plasma and tis-
sue homogenates were determined by spectrophoto-
metric reading of the plasma at 525 nm (DU 530,
Beckman Coulter, Danvers, MA, USA) as previously
described [30].
The methylene blue method [36] was used for H2S
measurements in the plasma since this method was the
one chosen in previous studies to establish the blood
levels of H2S increases in humans during shock [16,18].
We followed a similar protocol: after centrifuging 2.5 ml
of blood at 13,000 rpm for five minutes, 1 ml of plasma
was collected and 0.4 ml of zinc acetate (1%) was added
to the plasma to trap H2S. Then, 100 μl of a 20 mM
solution of N, N-Dimethyl-p-phenylenediamine sulfate
(Sigma, St Louis, MO, USA) in 7.2 N hydrochloric acid
(Sigma), and 100 μl of a 30 mM iron chloride solution
(Sigma) in 1.2 N hydrochloric acid were added to the
plasma, producing a blue dye proportional to H2S con-
centration. Throughout the procedure, every precaution
was taken to prevent the samples from being in contact
with air: the blood was collected in syringes that were
immediately capped, and was then transferred to vials,
which were completely filled, capped and centrifuged.
After centrifugation, the plasma was collected and the
reagents were immediately added. The same procedure
(including centrifugation) was applied to phosphate-buf-
fered saline (PBS) solution containing a known amount
of H2S (concentration 100 μM). The H2S concentration
was obtained after 20 minutes by adding 0.5 ml of tri-
chloroacetic acid (TCA) 10% (to remove the proteins),
centrifuging the solutions (10 minutes at 13,000 rpm)
and reading the absorbance of the supernatants at 670
nanometers (spectrophotometer Beckman Coulter DU
530). A calibration curve for H2S concentration was
established, and for each experiment, a PBS solution
was used as the blank.
In order to assess the ability of the plasma to oxidize
exogenous H2S, 0.6 ml of plasma was mixed with 0.6 ml
of PBS. NaHS (sodium hydrosulfide hydrate, Sigma-
Aldrich) solution was added to the diluted plasma, so
that the final concentration of H2S was 100 μM. The
vials were entirely filled with diluted plasma and as soon
as H2S was added, the vials were capped to avoid contact
with air. Two minutes later, residual H2S concentration
was measured at ambient barometric pressure after appli-
cation of 0.5 ml of TCA 10% (Sigma-Aldrich) prior to the
final centrifugation (13,000 rpm for 10 minutes), and the
absorbance was read at 670 nm.
The same approach was used with the homogenates of
hearts and kidneys harvested immediately after cardiac
arrest. The organs were thoroughly rinsed in PBS, frozen
in liquid nitrogen and stored at -80°C for later analysis.
They were then thawed in ambient air, weighed and
homogenized (Tissue-Tearor, Biospec, Bartlesville, OK,
USA) in PBS (50% w/v for kidney, 25% w/v for heart).
The homogenates were then centrifuged at 13,000 rpm
for 15 minutes; 1.35 ml of supernatant was collected and
mixed with the corresponding volume of NaHS solution
to obtain a final concentration of 100 μM following the
same procedure as for the plasma. Again, the vials were
entirely filled with supernatant and as soon as H2S was
added, the vials were capped to avoid contact with air.
Residual H2S concentration was determined after two
minutes.
As whole blood is known to readily oxidize H2S, we also
sought to determine the resolution of the methylene blue
method applied to the blood by adding known concentra-
tions of H2S in fresh blood from three sham rats and then
measuring, for two minutes, H2S concentrations using the
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very same procedure. Again the same measurements were
made with the same timing using PBS solution.
TNF-alpha was measured in the plasma samples in
duplicates using an ELISA OptEIA kit (BD Biosciences,
San Diego, CA, USA).
Statistical analysis
All results are presented as mean ± SD. All parameters
were compared between pre-bleeding and post-bleed-
ing periods using a one-way ANOVA in each group.
ABP, V˙I and V˙O2 were also analyzed in each group
before and after each of the five bleeding periods using
ANOVA for repeated measurements; post-hoc compari-
sons were performed using a Bonferroni correction
(SigmaStat 2.0, SPSS Inc, San Jose, CA, USA). Finally,
the control and vitamin B12 groups were compared
with ANOVA, while survival rates were compared
between the two groups using a logrank test [37]. For




Control animals (n = 8)
Figure 1 displays recordings of the response to the
hemorrhage protocol in two different rats, while Table 1
reports the averaged data. Hemodynamic, ventilatory
and metabolic responses were qualitatively similar in all
control rats. Typically, each of the five three-minute
bleeding periods induced a drop in arterial pressure,
minute ventilation, V˙O2 and V˙CO2 . Between the bleed-
ing periods, all the parameters tended to return progres-
sively to their baseline values (Figures 1 and 2). This
recovery was interrupted by the subsequent bleeding
periods repeated after six minutes and was blunted over
time. At the end of the bleeding periods (30 minutes),
mean ABP, V˙I , V˙O2 and V˙CO2 were significantly
reduced by 68%, 44%, 56% and 51% respectively (see
actual data in Table 1). Blood lactic acid increased sig-
nificantly (P = 0.001) (Table 1). Two different profile
patterns (Figure 1) were observed following the bleeding
procedure: in five animals, arterial pressure increased
slowly towards pre-bleeding levels before subsiding
again until death occurred from primary respiratory or
cardiac arrest, within two hours following the onset of
bleeding. In the three remaining animals, arterial pres-
sure, minute ventilation, V˙O2 and V˙CO2 continued to
decrease until death (Figure 1), which occurred within
one hour. The survival rate vs. time is shown in Figure
3. The O2 deficit which averaged 122 ± 23 ml/kg at the
end of the bleeding period (Figure 4 and Table 1)
reached 338 ± 88 ml/kg at the moment of death.
Vitamin B12 treated rats (n = 9)
The absorbance spectra of the plasma of the animals
treated with vitamin B12 clearly showed a peak of
absorbance at 525 nm (Figure 5A), corresponding to a
concentration of 185 ± 216 μM/l. No peak of absor-
bance at 525 nm was observed in the plasma of any of
the control rats (Figure 5A).
As shown in Figure 2 and Table 1, the changes in
ABP, minute ventilation, V˙O2 , V˙CO2 and lactate before,
during and after the bleeding periods were similar in the
group treated with vitamin B12 and in control animals.
The time course of O2 deficit was also the same in the
two groups of rats (Figure 4A). O2 deficit accumulated
progressively during the bleeding period, reaching 118 ±
45 at 30 minutes (Table 1, NS vs controls, P = 0.98).
When vitamin B12 and control rats were combined, O2
deficit and lactate level at the end of bleeding were sig-
nificantly correlated (Figure 4B, r2 = 0.79). The O2 defi-
cit at the time of death was 265 ± 30 ml/kg (Table 1,
NS vs controls, P = 0.10).
H2S measurements
Control animals
According to our standard curve, a concentration of
100 μM H2S resulted in an absorbance of 1.41 at 670
nm; the relationship between the concentration of H2S
and the absorbance was linear up to 3 μM while it was
possible to identify the presence of H2S at a minimal
value of 1.5 μM (absorbance 0.005). We did not find
any changes in the level of H2S added to PBS which
were analyzed following the very same procedure as the
blood (including centrifugation): the absorbance of a
solution of H2S in PBS analyzed immediately after sam-
pling from the “mother” solution dropped by 3.2% fol-
lowing the procedure applied to the blood (n = 12).
Centrifugation for 10 minutes decreased the absorbance
by 1.2%. Absorbance readings of the plasma before the
shock averaged 0.014 ± 0.015 (Figure 5B). According to
the standard curve, such an absorbance would corre-
spond to a theoretical H2S concentration of 8.5 ± 2.9
μM. However, the profile of absorbance over the visible
spectrum was markedly different from that of a PBS
solution containing H2S at a concentration that would
reach a similar absorbance at 670 nm; as shown in
Figure 5B, the absorbance of the plasma was high at
400 nm and decreased continuously as the wavelength
was increased with a lack of peak of absorbance at
670 nm, in major contrast to the PBS solution. In other
words, in the absence of absorbance peak at 670 nm,
the value of absorbance of 0.014 ± 0.015 in the plasma
did not reflect the presence of methylene blue - and
thus H2S at approximately 8 μM - but should be viewed
as a marker of turbidity.
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Figure 1 Examples of recordings in two rats during and following acute hemorrhage. The breath-by-breath inspiratory flow ( V˙ ), arterial
blood pressure (ABP), minute ventilation (V˙I ), body temperature (θ), carbon dioxide production (V˙CO2 ) and oxygen uptake (V˙O2 ) are
displayed. Interruptions in ABP recording are due to blood withdrawal during each of the bleeding periods. Note the drop in arterial pressure,
minute ventilation, V˙O2 and V˙CO2 , during each bleeding period (see text for more details). At the end of the five bleeding periods, all
variables continued to either decrease slowly until death occurred (panel A, this response was observed in three out of eight control rats), or
ABP, V˙I , V˙CO2 and V˙O2 rose transiently before subsiding again, leading to a fatal outcome (panel B, this response was observed in five out
of eight control rats). The vertical arrow corresponds to the final cardio-respiratory arrest.
Table 1 Hemodynamic and metabolic variables before and at the end of the bleeding period.
Control (n = 8) Vitamin B12 (n = 9)
Pre-bleeding End of bleeding Pre-bleeding End of bleeding
Mean ABP (mmHg) 80 ± 12 26 ± 3* 79 ± 7 29 ± 7*










6.55 ± 0.60 3.23 ± 0.70* 6.42 ± 1.14 2.66 ± 1.03*
Lactates (mM/l) 1.88 ± 0.50 6.35 ± 1.44* 1.53 ± 0.21** 6.63 ± 2.09*
PO2 (mmHg) 81 ± 5 90 ± 11 72 ± 9** 86 ± 11*
PCO2 (mmHg) 36 ± 4 31 ± 7 33 ± 8 29 ± 5
TNF-alpha (pg/ml) - 1,301 ± 1,175 - 732 ± 869
O2 deficit (ml/kg) - 122 ± 23 - 118 ± 45
Values are mean ± SD. *P < 0.05 vs pre-bleeding values. ** P < 0.05 vs control rats.
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Similar results were found at the end of the bleeding
period (when O2 deficit reached 122 ± 23 ml/kg) with
an absorbance of 0.016 ± 0.009 at 670 nm. No peak was
observed and, just like before the bleeding period, a pro-
gressive decrease in absorbance from 400 to 700 nm was
found (Figure 5B). This profile of absorbance and the
lack of peak at 670 nm were observed in every animal
with no exception.
Vitamin B12 treated animals
There was no significant difference between the absor-
bance at 670 nm in control animals and following vita-
min B12, both prior (0.017 ± 0.009) and following
(0.029 ± 0.018) the period of bleeding (Figure 5A). Just
like in the control group and in major contrast to the
PBS solution, no peak could be identified at 670 nm sug-
gesting that H2S concentration in the plasma, if any,
could not be higher than a few μM.
Oxidation of 100 μM H2S by the plasma before and
during shock
As shown on Figure 6A, two minutes after adding 0.1 ml
H2S to pre-bleeding plasma to reach a final concentration
of 100 μM, residual H2S concentration was 9.2 ± 0.9 μM
in the control plasma and 7.7 ± 0.8 μM in the plasma of
the animals which received vitamin B12 (P < 0.01).
No change in H2S concentration was found in the PBS
solution over two minutes. The ability of the plasma to
oxidize H2S remained unchanged at the end of the bleed-
ing period, with residual plasma H2S concentrations of
10.0 ± 1.0 and 7.2 ± 1.7 μM for the control and vitamin
B12 groups respectively (P < 0.01). For the whole blood,
the absorbance spectra of H2S added in sham rat blood
at three different concentrations (50, 100 and 150 μΜ) is
displayed on Figure 6B along with the corresponding
residual H2S concentrations. Within five minutes, initial
Figure 2 ABP, V˙I and V˙O2 before and after each bleeding periods, in control (A) and vitamin B12 treated rats (B). The dashed lines
represent the bleeding periods. ABP, V˙I and V˙O2 dropped during each blood withdrawal, rising again when bleeding was stopped but
without reaching their previous values. There was no difference between control and vitamin B12-treated rats for either parameter. *P < 0.05 vs
pre-bleeding baseline (period 1).
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H2S concentrations in blood of 50,100 and 150 μΜ
dropped by 90, 92 and 75% respectively.
Oxidation of 100 μM H2S by tissue homogenates
As shown on Figure 7B, two minutes after adding 0.15 ml
H2S to the supernatant of kidney homogenates to reach a
final concentration of 100 μM, residual H2S concentration
was 50.2 ± 4.7 μM in control kidney homogenates and
34.8 ± 12.9 μM in kidney homogenates of the animals
which received vitamin B12 (P < 0.01). In the same condi-
tions, residual H2S concentrations in heart homogenates
were 31.3 ± 0.9 and 30.5 ± 0.9 μM for control and vitamin
B12-treated rats respectively (Figure 7C, NS). In vitamin
B12-treated rats, hydroxocobalamin concentrations were
47 ± 57 μM in kidney homogenates (Figure 7B), and
below the threshold of detection (30 μM) in heart homo-
genates except for two animals (Figure 7C). Concentra-
tions did not change in the PBS solutions.
Mortality and vitamin B12
There was no difference in time to death (59 ± 26 vs 65 ±
26 min) or mortality rates over time between vitamin B12
and control rats (Figure 3).
Plasma TNF-alpha
There was very large intra-group variability but no sta-
tistically significant difference in TNF-alpha plasma
levels between vitamin B12 treated and control rats (P =
0.398, Table 1).
Figure 3 Survival rates. Panel A, survival rate (in %) in the control (open circles) and vitamin B12-treated rats (closed circles). Time zero
corresponds to the onset of the bleeding protocol. All rats survived the bleeding period (30 minutes), about 50% were still alive after 60
minutes, and no rats survived after 120 minutes. There was no difference in the survival rates between the two groups (logrank test). Panel B
displays the individual survival times for the two groups. There was no significant difference in the mean survival time between control and
vitamin B12 treated rats (65 ± 26 vs 59 ± 26 min).
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Discussion
In major contrast to previous reports in humans [18]
and in animal models [11], we did not observe any
increase in blood H2S concentration in a model of lethal
untreated hemorrhagic shock in urethane anesthetized
rats, despite major O2 deficit, hyperlactacidemia and sys-
temic inflammation. In addition, following the bleeding
period, the plasma of every animal, as well as the super-
natants from the heart and kidney kept a very high abil-
ity of oxidizing/complex large (toxic) amounts of sulfide.
Finally, following injection of a very large dose of vita-
min B12, the ability to oxidize H2S by the plasma and
the kidney was enhanced in proportion to the local vita-
min B12 concentration. However, the survival rate, O2
deficit or the various markers of the severity of the
shock were not affected by the presence of μM levels of
hydroxocobalamin. These findings do not support the
hypothesis that endogenous H2S does accumulate in the
blood or in most tissues and contributes to the severity
of hemorrhagic shock induced oxygen deficit [11,18].
Rat model
To investigate the putative role of endogenous hydrogen
sulfide during hemorrhagic shock induced cellular
hypoxia, we used the urethane-anesthetized rat as an
experimental model. Withdrawing 25 ml/kg of blood
within 30 minutes produced a dramatic reduction in
ABP, V˙O2 and V˙CO2 along with an increase in lactic
acid and in the respiratory quotient ratio. This hemor-
rhage protocol led to a fatal outcome in 50% of the ani-
mals within one hour following the bleeding onset, which
paralleled the magnitude of O2 deficit and hyperlactaci-
demia. All animals died within two hours. This relatively
low survival rate of hemorrhagic shock in rats compared
to larger [38,39] or non-anesthetized animals [40] is not
unexpected. Indeed, not only anesthesia alone is likely to
affect the normal ability of the circulatory and respiratory
systems to respond to an acute reduction in volemia
[31,41], but urethane, by itself, significantly blunts the
normal cardio-vascular regulation [42]. Nevertheless, the
fatal outcome we observed in our study appears to be
Figure 4 Oxygen deficit in control vs treated rats. Panel A, time course of O2 deficit in four control (dashed lines) and six vitamin B12-treated
(continuous lines) rats, from the onset of bleeding (time 0) to death. In all rats, O2 deficit accumulated continuously during the bleeding period
reaching 120 ml/kg at the end of the bleeding protocol (vertical arrow). Following the bleeding period, O2 deficit continued to accumulate in a
ramp-like fashion, while in the rats that survived much longer, O2 deficit remained constant. There was no significant difference in the time
course of O2 deficit between control and vitamin B12-treated rats. Panel B, relationship between O2 deficit and plasma lactate levels at the end
of bleeding periods in control (open circles) and vitamin B12-treated (closed circles) rats (r2 = 0.79).
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Figure 5 Absorbance of the plasma and H2S concentrations. Panel A, absorbance spectra of the plasma collected at the end of the overall
bleeding period in control (open circles) and vitamin B12-treated (closed circles) rats. There was a clear peak of absorbance at 525 nm in
vitamin B12-treated rats corresponding to a vitamin B12 plasma concentration of 185 ± 216 μM/l. No peak was observed in any of the control
rats. At 670 nm, that is, the absorbance wavelength of the methylene blue, no peak was observed, neither in control nor in the vitamin B12-
treated rats. Panel B, absorbance spectra, between 400 and 700 nm, of the plasma of the control rats, before (open triangles) and at the end of
the bleeding period (closed squares). The observed absorbance values at 670 nm would theoretically correspond to a H2S concentration of
around 4 μM/l in the dilute plasma (or 8 μM/l in the plasma, see text for additional comments), as illustrated using a control solution
(phosphate-buffered saline, PBS) containing H2S (4 μM) (open diamonds). The lack of peak of absorbance in the plasma at 670 nm along with
the pattern of absorbance over the visible spectrum (continuous decrease of absorbance from 400 nm) strongly suggest that it is the turbidity
of the medium which could account for this apparent presence of H2S in the plasma.
Figure 6 Plasma and H2S. Panel A, residual H2S concentration ([H2S]r), two minutes after addition of 100 μM H2S in the plasma of control
(open circles) and vitamin B12-treated (closed circles) rats. [H2S]r is expressed in percentage of the concentration of 100 μM present in a control
PBS solution analyzed at the same time as the plasma. Within two minutes, H2S concentrations decreased by more than 90% in control and
vitamin B12-treated rats respectively, with a significant difference between the two groups (*P < 0.05). Panel B, absorbance spectra of H2S added
to sham rat whole blood at 50, 100 and 150 μM and measured after two minutes. In the inset, the percentage of residual [H2S] ([H2S]r),
corresponding to the absorbance at 670 nm, is shown for each initial concentration. Depending of the initial [H2S] ([H2S]i), exogenous H2S
concentrations decreased between 92 and 75%.
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both quantitatively and qualitatively similar to that
observed in larger mammals [1,3,5]. A number of charac-
teristics of our model should, however, be discussed.
First, O2 deficit per kilogram was much larger for a given
volume of blood withdrawn than in larger animals, such
as pigs [1] or dogs [4,5]. This larger reduction in V˙O2
during and following the hemorrhage was associated to a
higher baseline specific (per kilogram) metabolic rate,
typical of small mammals, akin to hypoxia induced meta-
bolic depression [43-46]. More specifically, resting V˙O2
in our rat model averaged 15 ml/kg (about four times the
expected V˙O2 level in humans), as previously reported
[45,47], with a O2 deficit reaching 300 ml/kg over a one-
hour period, up to three times the deficit reported in
sheep or dogs during bleeding protocols leading to simi-
lar survival rates [2]. This large V˙O2 deficit can be
accounted for by the magnitude of blood flow redistribu-
tion in small vs large animals [42,48], a reduction in
uncoupling protein activity, specific to small-sized mam-
mals [49] and, eventually, a genuine reduction in oxida-
tive mitochondrial activity resulting in lactic acidemia.
Although extremely variable between animals, an eleva-
tion in blood level of TNF-alpha was found in all rats at
the end of the bleeding period.
It is interesting to note that just like in hypoxia-
induced hypometabolism [43] or when unloading
venous return [50], ventilation decreased with V˙O2 and
V˙CO2 but with a relative hyperventilation (Figure 2);
this discrepancy between the drop in gas exchange rate
and V˙I resulted in all animals in a progressive reduction
in PaCO2 and increase in PaO2 (Table 1). Finally, the
relative higher values of V˙CO2 than V˙O2 at the end of
the bleeding protocol are likely to be accounted for by
the equimolar transformation of the bicarbonate into
CO2 (buffering of the developing metabolic acidosis).
This could have resulted in a relative increase in CO2
output, akin to the rise in the respiratory quotient ratio
typical of heavy exercise with hyperlactacidemia [51].
Hemorrhagic shock and H2S
H2S has been shown to be present in the plasma at con-
centrations between 25 and 50 μM and to increase up
to 100 μM in humans during various types of shock
[18]. Plasma H2S concentration in these patients [18]
correlates with the severity of the shock. The very pre-
sence of H2S in the plasma has already been challenged
on methodological and physiological grounds [20,28].
Since the proteins present in the blood (hemoglobin)
Figure 7 Ability of plasma and tissue homogenates to oxidize/complex H2S. Individual relationship between vitamin B12 concentration and
residual H2S concentration ([H2S]r) determined two minutes after addition of 100 μM H2S in the plasma (Panel A), in the supernatant of kidney
homogenates (Panel B) and heart homogenates (Panel C) in all the control (open circles) or vitamin B12-treated (closed circles) rats. [H2S]r is
expressed in percentage of the initial concentration of 100 μM present in a control PBS solution analyzed at the same time as the medium. In
the presence of vitamin B12, very large amounts of H2S can be oxidized both in the plasma and in the kidney. In the heart, the concentration of
vitamin B12 was too low to be measured by our method (except for two rats) and no visible effect on high μM concentration of exogenous H2S
could be identified (see text for additional comments).
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complex and/or catalyze very large amounts of sulfide
[20], trivial levels of H2S, if any, are expected to be
found in the plasma in baseline conditions, as shown by
Furne et al. [28] and Whitfield et al. [20]. Whitfield et
al. reported no measurable level of H2S [20] after addi-
tion of 10 μM of H2S in rat blood before applying a
method similar to that used in the present study.
Besides, the levels reported both in baseline conditions
and in shock [11,16,18] appear to be higher than those
expected to be found during severe H2S intoxication
[52], wherein mitochondrial activity is inhibited.
The method used to determine H2S in previous studies
[11,16,18] was developed by Siegel et al. [36] and relies
on the transformation of one molecule of H2S and two
molecules of N, N-dimethyl-p-phenylenediamine into
one molecule of methylene blue (MB). H2S concentration
can then be determined by measuring the absorbance of
the solution at 670 nm (methylene blue). One of the lim-
its of this method is directly related to the fact that the
absorbance is proportional to the concentration of a
given molecule - which color is the complementary of
the light wave absorbed - if and only if none of the inci-
dent light is scattered by dispersed particles or molecules.
The presence of a minimal level of turbidity can alter the
absorbance of light at any wavelength irrespective of the
actual “color” of the plasma, unless a genuine peak of
absorbance can be found between 600 and 700 nm
(Figure 5). We found that, even after application of TCA
to remove the proteins and multiple centrifugations, a
significant absorbance can be found at 670 nm. Using a
broader spectrum of wavelengths, one can show that the
Beer-Lambert law cannot be applied to identify small
concentrations of H2S in plasma. This is also illustrated
in Figure 5 where the spectrum of absorbance of the
plasma after reaction with the reagents to form MB is
very different from that of a solution containing H2S at
the hypothetical concentration corresponding to a similar
absorbance. These data suggest that if the method devel-
oped by Siegel is to be used in the plasma, determination
of H2S concentrations based on the absorbance of light
at only 670 nm can be misleading, yielding to erroneous
findings of H2S. This issue has already been highlighted
by Hughes et al., who reported that the linear depen-
dence of absorbance on the MB concentration was only
valid for concentrations of H2S much lower than those
reported in all these studies; these authors also recom-
mended the use of the spectra of absorbance between
550 and 700 nm [53]. Using a different method, based on
the monobromobimane derivatization [54], Tokuda et al.
reported H2S plasma concentrations ranging at best
between 2 to 4 μM, consistent with the present results,
and more importantly that H2S levels decreased, if any-
thing, in endotoxic shock in mice [55]. Volatilization of
H2S observed by De Leon et al. [56] when samples are
left in open air is unlikely to have occurred (see Method
and Result sections); since we took the precaution to
entirely fill all the vials and to cap them immediately, to
prevent any significant volatilization. The procedure used
for plasma H2S measurements (including centrifugation)
was applied as well to PBS solutions containing a known
amount on H2S (concentration 100 μM), and the level of
H2S was not affected. In addition, we previously found
that using this procedure, H2S concentration (in PBS or
saline solution) remained stable with a few percent drop
in concentration over one hour [30]. DeLeon et al.
reported similar results when they took the precaution to
close their chambers [56]. For the determination of the
ability of the plasma and tissues to oxidize exogenous
H2S, PBS solutions containing the same initial amount of
H2S were analyzed at the very same time as the plasma
or supernatant; H2S concentrations were unchanged in
PBS within the two-minute period we chose for our
determination and all results have been expressed in per-
centage of the concentration of 100 μM present in the
PBS solution analyzed at the same time and following the
same procedure.
Endogenous H2S in the tissues, vitamin B12 and
hemorrhagic shock
There is a spontaneous oxidation/complexation of H2S
in the plasma and the supernatant of tissues, which was
enhanced by μM concentrations of vitamin B12. The
latter was obtained following intraperitoneal injection of
vitamin B12 at a dose used during cyanide intoxication
(106 times the normal daily intake), as previously
reported [46,57,58]. The kidney and heart were chosen
as they are among the most important organs exposed
to the consequences of hemorrhage-induced ischemia.
In addition, our previous study [30] showed that the
ability of tissue homogenates of these organs to oxidize
H2S was clearly enhanced in vitamin B12-treated rats. In
that previous study, we found that vitamin B12 could
oxidize large amounts of H2S in direct relation to its
concentration, likely due to the presence of oxidized
cobalt [30]. We could establish that the presence of
10 μM vitamin B12 was able to oxidize 20% of a 100 μM
solution of H2S; at 50 μM, about 80% of the H2S was oxi-
dized within five minutes. This is consistent with our
present results, where vitamin B12 concentrations in the
plasma were found to be about 180 μM and could
decrease the exogenous H2S levels to 7.7 ± 0.8 μM
(significantly lower than control plasma; initial concen-
tration 100 μM), after two minutes. Similarly, about
50 μM of hydroxocobalamin were found in our kidney
homogenates, which in turn decreased H2S concentra-
tions by 65% (vs only 50% in control; initial concentration
100 μM). For the heart and, very likely, for some other
tissues, the spectrophotometric method of detection of
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vitamin B12 was not sufficient to demonstrate the pre-
sence of vitamin B12 (the threshold is about 30 μM [30]).
Incidentally, pM - and not μM - concentrations of hydro-
xocobalamin are expected to be present in the body
[59,60]; therefore, with the methodology used in the pre-
sent study we were unable to demonstrate whether low
μM concentrations of vitamin B12 were able to oxidize
H2S at the concentrations likely to be present in the
heart [28]. This is a very important point to consider as
our present results did not show that vitamin B12 was
absent from the heart or could not oxidize sulfide, but
within the very poor resolution of our method, no reli-
able conclusion could be drawn.
Hypoxic conditions have been proposed to decrease
H2S oxidation resulting in the accumulation of H2S [23].
This increase in H2S concentrations may, however,
occur only if PO2 decreases to extremely low levels [24],
similar to those expected to be found in the vicinity of
the mitochondria, suggesting to Olson [23,61] that the
site of action for endogenous H2S can only be the mito-
chondria. Studies trying to establish the actual amount
of H2S present and endogenously produced revealed
that at best nM changes in H2S concentrations can be
observed [46]. We speculate that low levels of vitamin
B12 could still be able to decrease such concentration of
H2S in our study [30].
The present study did not address the effect of reperfu-
sion, wherein production of cytokines and oxidative
stress are prominent. Patients or animal models who
showed an increase in plasma H2S concentrations [16,18]
were resuscitated, and the question of the putative role of
endogenous H2S will need to be tested during the critical
period of reperfusion.
Conclusions
There is no evidence that H2S can accumulate in the high
micromolar range in the blood and tissues (extravascular
compartment) during a lethal form of hemorrhagic
shock. The presence of cobalt (hydroxocobalamin) did
not affect any of the outcomes of the shock. These results
imply that H2S in the blood cannot be used as a marker
of hemorrhagic shock. The hypothesis that H2S could
accumulate during hemorrhagic induced tissular hypoxia
must be reconciled with the ability of tissues to oxidize
H2S.
Key messages
• Even during a severe form of hemorrhagic shock in
the rat, where a major O2 deficit is present, there is
no evidence for an increase in H2S concentration in
the blood.
• Injection of high doses of hydroxocobalamin,
although enhancing the ability of blood and kidneys
to oxidize exogenous H2S in vitro, does not improve
the survival, O2 deficit, lactacidemia or TNF-alpha
levels in this model of shock.
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